Welcome to Impact Factor, your weekly commentary on the most interesting new medical studies. This week: A study appearing in Nature Scientific Reports strongly suggests a link between vitamin D levels at birth and the subsequent risk for schizophrenia.
Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported.
A purified form of cannabidiol (CBD), the non-psychoactive compound in cannabis, shows potential for reducing psychosis in patients displaying schizophrenia-like mental illnesses, according to a new study published in JAMA Psychiatry.
Schizophrenia is a devastating and complex disease that can include a variety of specific clinical conditions. Drugs to treat schizophrenia have not advanced much beyond the 1960s; in many cases they are not very effective, and they have severe side-effects. The problem is that the cause of schizophrenia is unknown, and precisely how the drugs affect brain circuitry is also unknown.
health freedom alliance, 26 April 2016
Where is the name William Thompson in news reports on Tribeca and De Niro?
Matthew Hill, of the University of Calgary's Hotchkiss Brain Institute has published a Perspective piece in the journal Nature voicing his concerns about other academics and journalists who suggest that cannabis use causes schizophrenia.
Believe it or not, this question has been asked for well over 60 years by researchers who stumbled upon evidence that the removal of gluten from the diet results in improved symptoms, or conversely, that gluten grain consumption leads to higher prevalence of both neurological and psychiatric problems.
The dramatic rise of antipsychotic prescribing in youth occurred in conjunction with the illegal marketing of the drugs by their makers, resulting in multibillion-dollar settlements with the government